PT2 Disinfectant
Understanding Product Type 2 under GB BPR: what PT2 covers, where another product type may apply, and how to verify either product authorisation or a lawful transitional supply route.
Product Type 2 (PT2) under the Great Britain Biocidal Products Regulation (GB BPR) covers disinfectants and algaecides not intended for direct application to humans or animals, including appropriate private- and public-health surfaces and some water applications. Classification follows the intended use: human or animal drinking-water disinfection is PT5; preservation of cooling or process liquids is PT11; and food- or feed-contact surfaces are PT4. A product may be lawfully supplied in Great Britain either after product authorisation or under applicable transitional arrangements while the relevant active-substance precursor route and product type remain in the GB Review Programme. This guide explains how duty holders can check the correct route without treating an Article 95 listing as product authorisation.
What Is PT2 Under the Biocidal Products Regulation?
Product Type 2 (PT2) is defined under the Biocidal Products Regulation as covering 'Disinfectants and algaecides not intended for direct application to humans or animals.' This category encompasses products used for disinfection of surfaces, materials, equipment, and water in areas associated with private and public health - essentially, any environment where harmful organisms need to be controlled to protect people.
PT2 is distinct from other disinfectant product types. PT1 covers human hygiene biocidal products applied to skin; PT3 covers veterinary hygiene; PT4 covers food- and feed-area surfaces and equipment; and PT5 covers drinking water for both humans and animals. PT11 covers preservation of cooling and process liquids. A lawful status or use under one product type does not extend automatically to another.
PT2 status must be checked for the specific product, intended use and Great Britain supply route. An authorised product has an authorisation number and conditions of authorisation. A product lawfully supplied under transitional arrangements may not have an authorisation number and may not appear on an authorised-products list; its evidence instead concerns the applicable active-substance or precursor route and PT, Article 95 supply chain, transitional requirements and deadlines, and any relevant national requirements.
Applications That May Fall Within PT2
Swimming pools and spa pools are common PT2 applications. HSG282 asks spa-pool duty holders to use suitable treatment chemicals within a managed control programme. GB BPR compliance may be through product authorisation or lawful transitional supply; neither route removes the need to follow the product label, monitor water quality and verify performance in the actual system.
Disinfection of building hot- and cold-water systems for public-health purposes can fall within PT2 as part of a Legionella control programme under ACOP L8 and HSG274. If the treated water is drinking water for humans or animals, PT5 is relevant instead or additionally, according to the intended use. A PT4 food- or feed-surface use does not by itself cover water treatment.
Cooling towers and evaporative condensers require careful use classification. PT11 covers preservation of liquid used in cooling and processing systems; a separate disinfection purpose may fall within PT2 only where that intended use is supported. Cooling-tower notification and Legionella duties do not turn every cooling-water treatment into PT2, and they do not replace GB BPR checks.
HVAC equipment, humidifiers, decorative water features, fountains and industrial systems must likewise be classified by the claimed purpose and label rather than by location alone. Confirm the product type and stated use with the supplier, then retain the evidence for the applicable authorised or transitional route.
PT2 vs Other Product Types: Understanding the Differences
PT4 covers disinfection of food- and feed-area surfaces, materials and equipment where the stated use falls within that product type. It is not a generic category for changing rooms, pool surrounds or other public areas, and PT4 status does not automatically cover a building water system.
PT5 covers disinfection of drinking water for both humans and animals. A PT2 use does not cover drinking-water treatment unless the specific product is also lawfully supplied for PT5 and the label supports that use. ChloroKlean products are supplied in Great Britain under transitional arrangements for their stated product types; no claim of full product authorisation, EU authorisation or Northern Ireland authorisation is made.
PT11 covers preservation of liquids used in cooling and processing systems. It should not be collapsed into PT2 merely because a cooling system has Legionella risk. Establish the treatment purpose, system and claims first, then verify the relevant product type or types.
A complex site may therefore need evidence for several product types. Keep the authorised conditions or transitional-route evidence for each intended use, together with the current label, Safety Data Sheet (SDS), technical instructions and site risk assessment.
Authorisation and Transitional Supply Are Different Routes
HSE administers GB BPR in Great Britain. For an authorised PT2 product, HSE's assessment and resulting authorisation define the permitted uses, claims and conditions. Verify the exact product name, authorisation number, PT2 use and current conditions rather than relying on a general statement about the active substance.
Efficacy assessment requires the applicant to demonstrate that the product works against the target organisms at the claimed concentration and conditions of use. For a PT2 water treatment disinfectant, this typically includes testing against bacteria (such as Legionella pneumophila, Pseudomonas aeruginosa, E. coli), viruses, and potentially fungi and algae. The testing must follow recognised European standards (EN test methods) and demonstrate effective disinfection under realistic conditions.
Human health safety assessment examines the risks to operators handling the product, to people occupying treated spaces, and to bystanders who may be exposed indirectly. This includes toxicological assessment of the active substance and formulation, exposure modelling for different use scenarios, and specification of risk mitigation measures (such as PPE requirements and ventilation). The safety assessment also considers disinfection by-products that may be formed during use.
Environmental assessment considers exposure, fate and effects of the product and relevant by-products. Chlorine dioxide does not form chloramines and generally forms very little THM or HAA, but chlorite and chlorate require control through label dosing and measurement; it is not accurate to describe the treatment as producing zero or harmless by-products.
Where transitional provisions apply, lawful supply is not evidenced by an authorisation number. Check HSE's GB Review Programme and active-substance lists for the exact in-situ precursor route and PT2, confirm the active-substance supplier or product supplier meets the applicable GB Article 95 requirement, and obtain evidence that the product meets current transitional deadlines and national requirements. Article 95 listing addresses the supply chain; it is not product authorisation.
Choosing the Right PT2 Disinfectant for Your Application
Select a product by matching its lawful PT2 uses and label conditions to the target organisms, water or surface characteristics, temperature, pH, organic loading, materials and exposure pattern. Do not infer a claim from the active substance alone, and do not treat a generic product-type statement as permission for every PT2 setting.
Chlorine dioxide can be considered where its supported claims and site conditions fit the control programme. It forms no chloramines and typically very little THM or HAA, while forming chlorite and chlorate that must be managed. Biofilm and microbiological performance depend on concentration, contact time, demand, hydraulics and monitoring; superiority over another active should not be assumed.
For an authorised product, request the authorisation number and current conditions alongside its label, SDS, Technical Data Sheet (TDS) and relevant efficacy evidence. For a transitional product, request evidence for the applicable precursor route and PT in the GB Review Programme, Article 95 supply-chain compliance, current transitional requirements and deadlines, and any applicable national requirements. Absence from an authorised-product list is not by itself proof that a transitional product is unlawful.
Consider also the supplier's technical support capability. PT2 applications often involve complex water systems with site-specific challenges. A supplier who can provide site assessments, dosing calculations, monitoring guidance, and ongoing technical support adds significant value beyond the chemical product itself.
Enforcement and the Consequences of Non-Compliance
HSE can enforce GB BPR where a biocidal product is unlawfully made available or used. The relevant question is not simply whether a product appears on an authorised-products list, but whether it has either a current authorisation for the use or a lawful transitional basis and is used in accordance with the applicable requirements.
Following a public-health incident, regulators may examine product status, label compliance, dosing and monitoring records, the written control scheme and the suitability of the overall risk-management programme. Product status is important evidence, but it does not by itself establish whether every health-and-safety duty was met.
Keep a dated verification record and review it when HSE changes active-substance status, Article 95 entries, transitional deadlines or authorisation conditions. Seek regulatory advice where the route, intended use or product-type boundary is unclear.
Key Data & Statistics
PT2
Disinfectants and algaecides not intended for direct application to humans or animals
2 routes
Product authorisation or applicable lawful transitional supply in Great Britain
PT5
Product type for human and animal drinking-water disinfection
PT11
Product type for preservation of cooling and process liquids
How to Verify a PT2 Product's GB BPR Route
The evidence differs depending on whether the product is authorised or lawfully supplied under transitional arrangements.
| Feature | Authorised product | Lawful transitional supply |
|---|---|---|
| Primary status evidence | Product authorisation number and current authorisation conditions | Applicable GB Review Programme active substance or in-situ precursor route and PT2 |
| Product list expectation | Should be verifiable against HSE product information | May have no authorisation number and may not appear on an authorised-products list |
| Supply-chain check | Check any applicable Article 95 requirement as well as authorisation | Confirm the applicable GB Article 95 supplier or product-supplier route |
| Use boundary | Match the exact PT2 use and conditions | Match the stated use, precursor route, product type and transitional scope |
| Timing | Check that authorisation remains current | Check current transitional requirements, deadlines and national requirements |
| Operational evidence | Current label, SDS, TDS, efficacy evidence and site records | Current label, SDS, TDS, efficacy evidence and site records |
Article 95 listing is a supply-chain requirement, not product authorisation. Verify current HSE information for the specific product, route, product type and intended use.
How to Verify and Implement a GB BPR-Compliant PT2 Disinfectant
A practical check for either product authorisation or lawful transitional supply before implementing a PT2 use.
Identify Your PT2 Applications
Record each intended use and identify the correct product type from the purpose, not simply the location. Pools, spas and relevant public-health surfaces may be PT2; human and animal drinking water is PT5; cooling or process liquid preservation is PT11; food- and feed-contact surfaces may be PT4.
Identify the Product's Regulatory Route
Ask whether the specific product is authorised or supplied under transitional arrangements. If authorised, verify its authorisation number, PT2 use and conditions. If transitional, do not expect an authorisation number: obtain evidence for the applicable active-substance or in-situ precursor route and PT2 in the GB Review Programme, the Article 95 supply chain, current transitional requirements and deadlines, and applicable national requirements.
Evaluate Suitable Lawful Products
For each candidate, compare the stated PT2 uses, label conditions, efficacy evidence relevant to the target organisms and application, materials compatibility, system demand and by-product controls. ChloroKlean products are supplied for their stated Great Britain uses under GB BPR transitional arrangements; no full GB product authorisation or EU/NI authorisation is claimed.
Request Documentation and a Site Assessment
Request the evidence appropriate to the regulatory route, plus the current label, SDS, TDS and application-relevant efficacy information. Article 95 listing alone is not product authorisation or a complete transitional-status check. For installation advice, contact ChloroKlean on +44 333 772 7379 or at hello@chloroklean.com.
Implement and Document
Use the compliant product according to its label, supplier instructions and site risk assessment. Update the written scheme of control where applicable, COSHH assessment, monitoring procedures and product inventory. Retain the authorisation number and conditions where authorised, or the dated transitional-route evidence where not, and schedule review when regulatory status or deadlines change.
Expert Insights
About the Reviewer
Gavin Owen
Managing Director, ChloroKlean
Gavin Owen leads ChloroKlean's technical and commercial operations, bringing over 20 years of experience in industrial chemical distribution and water treatment. He oversees product development, regulatory compliance strategy, and the company's BPR compliance programme across PT2, PT4, PT5, and PT11 product types. Gavin works directly with water treatment professionals, facilities managers, and public health engineers across healthcare, leisure, food processing, and industrial sectors.
Related Products
BPR-compliant chlorine dioxide products available from ChloroKlean.
ChloroKlean Plus L20
Regenerative liquid chlorine dioxide supplied in Great Britain under GB BPR transitional arrangements for its stated uses. Confirm the applicable product type, precursor route and label for each installation; no full GB, EU or Northern Ireland product authorisation is claimed.
ChloroKlean Spa 500
Chlorine dioxide solution for stated pool and spa uses, supplied in Great Britain under applicable GB BPR transitional arrangements. Application and performance must follow the label, HSG282 where relevant and site monitoring.
ChloroKlean Surface Disinfectant
Surface-disinfection product supplied in Great Britain under applicable transitional arrangements for stated PT4 uses. Check the label: PT4 concerns food- and feed-area surfaces and equipment, not generic pool surrounds or changing areas.
Frequently Asked Questions
Common questions about this topic, answered by our technical team.
Important Safety and Regulatory Information
- A PT2 product used in Great Britain must be either authorised for that use or lawfully supplied under applicable transitional arrangements; not every lawful product has an authorisation number or appears on an authorised-products list.
- For an authorised product, verify the exact product, authorisation number, PT2 use and conditions. For a transitional product, verify the precursor route and PT in the GB Review Programme, Article 95 supply chain, applicable requirements and deadlines, and national requirements.
- Article 95 listing supports a supply-chain requirement; it is not product authorisation and does not establish that every intended use is lawful.
- PT5 covers human and animal drinking water; PT11 covers preservation of cooling or process liquids; PT4 covers supported food- and feed-area surfaces and equipment. Classify by intended use.
- All PT2 disinfectants must be stored, handled, and used in accordance with their Safety Data Sheet, product label, and COSHH assessment.
- Appropriate personal protective equipment (PPE) must be worn when handling concentrated disinfection products as specified in the product SDS.
- Water quality monitoring must be conducted in accordance with applicable guidance: HSG282 for spas, HSG274 for hot and cold water systems, ACOP L8 for Legionella control.
This information is guidance, not legal or regulatory advice. Consult HSE's current active-substance, Article 95, transitional and product-authorisation information and seek professional advice where the route or product-type boundary is unclear. ChloroKlean products are supplied for stated Great Britain uses under transitional arrangements; no full GB product authorisation or EU/NI authorisation is claimed.
Related Resources
Continue exploring our knowledge base and product information.
BPR Compliant Disinfectant Guide
How product authorisation and lawful transitional supply operate under GB BPR.
Spa Water Disinfection Guide
Spa-water disinfection under HSG282 using a product compliant for its stated PT2 use.
Chlorine Dioxide UK Supplier
How to assess a Great Britain supplier, documentation and the applicable GB BPR route.
Chlorine Dioxide vs Chlorine
Compare supported uses, operating factors and by-product profiles without assuming blanket superiority.
Chlorine Dioxide vs Bromine
Compare chlorine dioxide and bromine for pool and spa programmes, subject to product status and label.
Cutting Carbon in Water Treatment
Operational factors to assess when considering carbon impacts in water treatment.
Legionella Prevention in Water Systems
Risk assessment, system controls and verification for Legionella management in building water systems.
Cooling Tower Water Treatment
Cooling-tower controls and the distinction between PT11 liquid preservation and any supported PT2 use.
View Our Full Product Range
Explore ChloroKlean products supplied under GB BPR transitional arrangements for their stated uses.
Contact Us for PT2 Product Advice
Speak with our technical team about selecting the right PT2 disinfectant for your application.
Chlorine dioxide and hepatitis B: 2026 evidence
Laboratory HBV findings, commercial disclosures and why these are not ChloroKlean efficacy or dosing claims.
Sources & References
This article references guidance from the following authoritative sources:
- Biocidal Products Regulation (BPR, Regulation (EU) 528/2012)
ECHA - European Chemicals Agency
- GB Biocidal Products Register
HSE - Health and Safety Executive
- In situ generation: active substances vs biocidal products
HSE - Health and Safety Executive
- GB Article 95: the basics
HSE - Health and Safety Executive
- GB Review Programme for existing biocidal active substances
HSE - Health and Safety Executive
- BPR active substance lists for GB and NI
HSE - Health and Safety Executive
- HSG282: The control of legionella and other infectious agents in spa-pool systems
HSE - Health and Safety Executive
- HSG274 Part 2: The control of legionella bacteria in hot and cold water systems
HSE - Health and Safety Executive
- ACOP L8: Legionnaires' disease - Control of legionella bacteria in water systems
HSE - Health and Safety Executive
- Notification of Cooling Towers and Evaporative Condensers Regulations 1992
UK Government - UK Government Legislation
External links open in a new window. ChloroKlean is not responsible for the content of external websites.